MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,838 | -36.9% | 134 | -47.7% | 0.00% | 0.0% |
| Q2 2023 | $9,250 | +227.3% | 256 | +236.8% | 0.00% | – |
| Q1 2023 | $2,826 | -86.6% | 76 | -83.7% | 0.00% | -100.0% |
| Q4 2022 | $21,114 | -69.8% | 466 | -53.5% | 0.00% | -77.8% |
| Q3 2022 | $70,000 | +48.9% | 1,002 | +42.9% | 0.01% | +50.0% |
| Q2 2022 | $47,000 | +113.6% | 701 | +161.6% | 0.01% | +100.0% |
| Q1 2022 | $22,000 | +1000.0% | 268 | +1961.5% | 0.00% | – |
| Q4 2021 | $2,000 | -77.8% | 13 | -75.0% | 0.00% | -100.0% |
| Q3 2021 | $9,000 | +350.0% | 52 | +271.4% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 14 | -12.5% | 0.00% | – |
| Q1 2021 | $3,000 | -62.5% | 16 | -54.3% | 0.00% | -100.0% |
| Q4 2020 | $8,000 | +60.0% | 35 | -96.5% | 0.00% | -50.0% |
| Q1 2017 | $5,000 | +25.0% | 989 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $4,000 | – | 989 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |